Female GU Flashcards
Ovarian tumours:
Types of Ovarian Cancer
Types of Ovarian Cancer
Frequency of Major Ovarian Tumours
Epithelial tumours: arise from surface epithelial cells
- Cystadenoma/cystadenocarcinoma Serous cystadenoma
- Ovarian serous cystadenocarcinoma
- Borderline serous cystadenoma
- Ovarian mucinous cystadenoma
- Ovarian mucinous cystadenocarcinoma
- Primary peritoneal serous carcinoma associated with BRCA1
Ovarian cystadenom
Ovarian cystadenoma is a broad term given to a certain types of ovarian epithelial tumours. This can include
- ovarian serous cystadenoma
- ovarian borderline serous cystadenoma
- ovarian mucinous cystadenoma
- ovarian borderline mucinous cystadenoma
- ovarian cystadenofibroma
Serous cystadenoma
- Most common tumour of the ovary
- Benign
- Commonly bilateral (15%)
- Present as large cystic lesions, usually unilocular, the lining of the cyst is flat or may contain small papillary projections.
- Pancreatic serous cystadenomas also contain stroma similar to ovarian stroma
Ovarian serous cystadenocarcinoma
malignant form of ovarian serous tumour
- It is the most common type of ovarian malignancy (50-80% of all malignant epithelial ovarian tumours)
- Usually high grade (80%), p53 positive
- high grade nuclear features (e.g. nuclear pleomorphism, abnormal mitotic figures)
- characterised by intratumoural heterogeneity
- nearly ubiquitous p53 positivity
- low grade (5%)
- Though to represent malignant degeneration of serous cystadenoma
- Incidence peaks in 60-70s
**Risk factors: **
oestrogen exposure (nulliparity, early menarche, late menopause)
**Markers: **
elevated CA-125 (>90% of cases)
Imaging features:
* Cystic mass with substantial solid component
* Calcification uncommon but may be seen (12%)
* Frequently BILATERAL (65%)
* Ascites and peritoneal nodularity → metastatic disease
**MRI: **
cystic portions are T1 dark unless there has been intralesional haemorrhage (keep in mind mucinous tumours also have a brighter T1 appearance in the cystic component), solid components restrict and enhance
Theorised that serous carcinomas may arise from fallopian tube or ovary → therefore patients who are high risk (BRCA) have salpingo-oopherectomy rather than simple oopherectomy
Almost all ovarian carcinomas arising in women with BRCA1 or BRCA2 mutations are high-grade serous carcinomas with TP53 mutations.
Borderline serous cystadenoma
- lie in the intermediate range in the spectrum of ovarian serous tumours and represent approximately 15% of all serous tumours
- Present at younger age than cystadenocarcinoma
- Cystic lesions with profuse papillary projections - middle of the road between cystadenoma and cystadenocarcinoma
- Prognosis better than for cystadenocarcinoma, even in presence of transovarian spread
- CA-125 typically mildly elevated
Ovarian mucinous cystadenoma
- Benign
- Less common than serous
- Comprise of 80% of mucinous ovarian tumours, and 25% of all benign ovarian tumours
- tumours are lined by columnar epithelium, typically similar to endocervical epithelium. These cells secrete thick, gelatinous mucin which fills the locules
Imaging features:
* Larger than serous at presentation, unilateral, multilocular
* Bilateral 5%
* MRI multiple locules with fluid of various viscosity → “stained glass” appearance on T1 and T2
- Mutation of KRAS proto-oncogene
- Associated with psuedomyxoma peritonei, marked by extensive mucinous ascites, cystic epithelial implants on the peritoneal surfaces, adhesions, and frequent involvement of the ovaries
- Most common cause of pseudomyxoma is actually appendiceal in origin
- Causes death by SBO
- Because the majority of primary mucinous ovarian tumors are unilateral, bilateral presentation of mucinous tumors always requires exclusion of a non-ovarian origin.
- Primary peritoneal serous carcinoma associated with BRCA1
- The nodular pattern of disease and presence of disease in the gastrohepatic ligament are associated with significantly higher odds of BRCA1 mutant disease.
Ovarian mucinous cystadenocarcinoma
- Rare 5-10% of all ovarian mucinous tumours, malignant
- development of mucinous cystadenocarcinoma has been very rarely associated with malignant transformation of a mature cystic teratoma
Imaging features:
* Multilocular, stained glass, unilateral, similar to mucinous cystadenoma
* Greater solid. Nodular tissue suggestive of malignancy
- Tx: tumour debulking, neoadjuvant chemo pre/post op
- estimated median survival when presenting at an advanced stage is significantly shorter (14 months) compared to ovarian serous cystadenocarcinoma (42 months)
Primary peritoneal serous carcinoma associated with BRCA1
The nodular pattern of disease and presence of disease in the gastrohepatic ligament are associated with significantly higher odds of BRCA1 mutant disease.
Endometrioid
Definition:
Malignant epithelial neoplasm of the ovary. Commonly associated with endometrial carcinoma.
Both endometrioid and clear cell carcinomas are frequently associated with endometriosis
Epidemiology and Associations:
* 2nd most common ovarian ca, 10-15% of all ovarian cancers. Epithelium resembles benign or malignant endometrium.
* 15-20% of cases occur in the setting of concurrent endometriosis although direct origin from ovarian surface is possible.
* In 15-30% of cases an independent endometrial carcinoma is seen.
* synchronous endometrial carcinoma or endometrial hyperplasia may be present in up to a third of cases
* the endometrial abnormality is thought to represent an independent, primary lesion rather than metastatic disease
* endometrioid carcinoma is the most common malignant neoplasm arising within an endometrioma, although overall this is an uncommon occurrence
Pathogenesis/Organisms:
* PTEN, KRAS and catenin mutations frequently occur.
* TP53 mutations are common for poorly differentiated tumours.
* 5 yr survival for stage 1 disease is 75%.
Morphology:
* Distinguished from serous or mucinous cancers by the presence of tubular glands resembling benign or malignant endometrium.
* Endometrial carcinomas present with solid and cystic areas of growth.
* 40% involve both ovaries and such bilaterality usually implies extension of the neoplasm beyond the genital tract.
* Low grade tumours with glandular pattern.
Complications:
* Metastasis
* Recurrence
Clinical Presentation:
* Abdominal fullness
* pain
* incidental.
* PV bleeding.
Brenner tumour
- Uncommon surface epithelial tumour of the ovary - 3% of ovarian epithelial neoplasms
- also known as transitional cell tumours if malignant (made up of >50% malignant cells)
- Most are benign, borderline malignant types are rare, if made up of more than 50% malignant cells they are known as TCC of the ovary
- Originally known as a transitional cell tumour due to histological similarity to urothelium (bladder) (histo: transitional cells covered by fibrous stroma, similar to neoplasms of the urothelium)
- Can rarely occur in other locations, including the testis
- Most commonly incidental findings at laparoscopy
- Brenner tumours are associated with another epithelial ovarian neoplasm of either the ipsilateral or contralateral ovary in ~30% of cases
Imaging features:
* small (usually <2cm) multilocular cystic mass with solid component, or mostly solid mass, calcifications ~85%
* Even with large tumour >10cm, there is often lack of local invasion, differentiating from other malignant ovarian neoplasms
Germ cell tumours: arise from oocytes
- Ovarian teratoma
Can contain bone, epithelium, muscle, fat, nerve, skin replete with hair, sebaceous glands, and tooth structures - Yolk sac tumor
- Dysgerminoma
- Ovarian choriocarcinoma (ie non-gestational choriocarcinoma)
Ovrian Teratoma
Subtypes
* Mature teratoma
* Immature teratoma
* Monodermal/Highly Specialised:
Mature teratoma
Definition:
Germ cell tumour of the ovary seen in young women in reproductive years.
Epidemiology and Associations:
* Karyotype is usually 46,XX
* Likely arising from ovum after first meiotic division.
* Characteristically cystic masses lined by squamous epithelium with adnexal structures
* Associated with paraneoplastic syndromes such as limbic encephalitis which can remit following tumour removal.
Morphology:
* Bilateral 10-15% of the time.
* Unilocular cyst containing hair and sebaceous material
* May find teeth and other calcified structures internally.
* Sometimes incorporated into the wall of a mucinous cystic neoplasm.
* 1% undergo malignant transformation, usually to SCC.
* Rarely there is no cystic component
Complications:
* Malignant degeneration most commonly to SCC
* Rupture
* Torsion
Immature teratoma
- Rare. Tissues resemble embryonal immature fetal tissue.
- Seen in prepubertal adolescents and young women. Mean age of 18 yrs.
- Bulky lesions with smooth external surface.
- Hair, sebaceous material, cartilage, bone and calcs may be present along with necrosis and haemorrhage.
- Immature neuroepithelium, cartilage, bone, muscle, other elements present
- Histological grade 1-3 based on proportion of tumour containing immature neuroepithelium.
- Grow rapidly, frequently penetrate the capsule and spread either locally or distant.
- Higher grade tumour confined to ovary treated with adjuvant chemo. Most recur within 2 yrs, and absence of disease beyond this point has excellent prognosis.
Monodermal/Highly Specialised:
Rare. Includes struma ovarii and carcinoid
ALWAYS unilateral
Struma Ovarii
* Falls under the umbrella of monodermal or highly specialised tumours.
* Thyroid tissue is the dominant or sole component
* Associated with thyroglobulin - can be a cause of hyperthyroidism
* Colloid components of Struma ovarii will likely be T2 dark. Signal dropout associated with fat within the lesion.
Carcinoid
* can produce sufficient 5-hydroxytryptamine to cause the carcinoid syndrome even in the absence of hepatic metastases, since ovarian veins are directly connected to systemic circulation.
* Primary ovarian carcinoid (always unilateral) must be distinguished from metastatic intestinal carcinoid, which is virtually always bilateral.
Struma carcinoid
* well differentiated neuroendocrine tumor admixed / juxtaposed with thyroid tissue
* Presumably arises from intestinal tissue found in teratomas
**Neuroectodermal cyst **
* lined by ependymal cells
Epidermoid cyst
* lined by squamous epithelium (no sebaceous glands present)
Dysgerminoma
- Dysgerminoma is the ovarian counterpart of testicular seminoma
- Some occur in patients with gonadal dysgenesis, including pseudohermaphroditism
- Seminoma of the ovary.
- Tend to occur in young adult females and adolescents.
- All are malignant but varying degrees of atypia. approximately ⅓ are aggressive
- If confined to ovary there is a 96% cure rate.
- responsive to chemotherapy, and even those that have extended beyond the ovary can often be cured. Overall survival exceeds 80%
- Unilateral in 80-90%
- Range in size from tiny to filling the pelvis.
- Grey-white. Soft and fleshy. Grow in sheets and cords.
Imaging features
* More aggressive lesion which will demonstrate restricted diffusion.
* T1 dark. T2 iso to dark
* Homogeneous enhancement pattern
Ovarian choriocarcinoma (ie non-gestational choriocarcinoma)
- Similar to testicular. Similar morphology to choriocarcinoma of placental origin.
- Extraembryonic origin, like yolk sac tumour.
- Histologically identical to more common placental lesions
- It is generally held that a germ cell origin can be confirmed only in prepubertal females, because after this age an origin from an ovarian ectopic pregnancy cannot be excluded
- Commonly exists in combination with other ovarian germ cell tumours, rarely seen as a pure choriocarcinoma.
- Ovarian choriocarcinoma is aggressive and have usually metastasised heamatogenously to the lungs, liver, bone and other sites at the time of diagnosis.
- Elevated hCG which helps with detecting recurrences.
- In contrast to choriocarcinomas arising in placental tissue, those arising in the ovary are generally unresponsive to chemotherapy and are often fatal.
Sex-cord stromal tumours:
- These ovarian neoplasms are derived from the ovarian stroma, which in turn is derived from the sex cords of the embryonic gonad.
- The undifferentiated gonadal mesenchyme eventually produces specific types of cells in both male (Sertoli and Leydig) and female (granulosa and theca) gonads, and tumors resembling all of these cell types can be identified in the ovary.
- Moreover, because some of these cells normally secrete estrogens (granulosa and theca cells) or androgens (Leydig cells), their corresponding tumors may be either feminizing (granulosa/theca cell tumors) or masculinizing (Leydig cell tumors).
arising from stroma of ovarian cells, can secrete hormones
* Granulosa cell tumour
* Sertoli-Leydig cell tumour
* Fibroma
* thecoma
* Meig’s Syndrome
Granulosa cell tumour
- Resemble granulosa cells of developing follicle.
- broadly divided into adult and juvenile granulosa cell tumors largely based on the age of the patient, but also on morphologic findings.
- ⅔ occur in post menopausal women
- 5% of all ovarian tumours. 95% are adult type.
- Granulosa cell tumors are of clinical importance for two reasons:
- (1) they may elaborate large amounts of estrogen, and
- (2) they may behave like low-grade malignancies
- Functionally active in prepubertal (juvenile type) → precocious puberty
- Functionally active in post menopausal/adult → endometrial hyperplastia, post menopausal bleeding, endometrial carcinoma, proliferative breast disease
- Occasionally produce androgens, masculinising patient
- Elevated tissue and serum levels of inhibin, a product of granulosa cells, are associated with granulosa cell tumors.
- Usually unilateral. Can be microscopic to huge.
- Call-Exner bodies may be present
- All granulosa cell tumours are potentially malignant, but difficult to tell malignant potential on histology
- Thecoma components may be present, and if thecoma cells are predominant, then almost never malignant
- Sometimes secrete large amounts of oestrogen:
- Proliferative breast disease
- Endometrial hyperplasia and carcinoma → PV bleeding
- (granulosa is your drag queen name → oestrogen secreting)
*
Sertoli-Leydig cell tumour
- Can be functional causing masculinisation and defeminisation (opposite of granulosa cell) (Yes, SIRtoli → masculinisation)
- Occur in women of all ages with peak in 2nd and 3rd decades.
- May block normal sexual development in children.
- Hilus cell tumors - (pure Leydig cell tumors), produce predominantly testosterone
Fibroma, thecoma and fibrothecomas
- Tumors arising in the ovarian stroma that are composed of either fibroblasts (fibromas) or plump spindle cells with lipid droplets (thecomas), or a mixture of both (fibrothecomas)
- Pure thecomas are rare but tumours in which these cells are predominant may be hormonally active
- Usually only occur in post menopausal women
- In contrast, fibromas as a rule are hormonally inactive
- Most common in middle aged women.
- T1 and T2 dark lesions without restriction (high ADC)
- Varying degrees of enhancement, usually delayed.
- Association with Meigs syndrome (Meg needs Fibre) (ascites and unilateral pleural effusion)
- Also associated with basal cell nevus syndrome
Fibroma
* Most common in middle aged women.
* T1 and T2 dark lesions without restriction (high ADC)
* Varying degrees of enhancement, usually delayed.
* Association with Meigs syndrome (Meg needs Fibre)
thecoma
Generally only occur in postmenopausal women.
Meig’s Syndrome
defined as the presence of ascites and pleural effusion in association with a benign, usually solid ovarian tumour, most commonly an ovarian fibroma (80-90%), but can be with others
Pleural effusion tends to be right sided (70% of cases)
Benign effusions, which resolve after resection of the primary pelvic tumour
**Ddx: **
* malignant ascites and pleural effusion in the presence of an aggressive ovarian tumour
* pseudo-Meigs syndrome: benign reversible pleural effusion in the presence of a primary tumour other than solid ovarian tumours, e.g. broad ligament leiomyoma